Publikationen von Moritz J. Rossner

Wehr, M. C.; Hinrichs, W.; Brzózka, M. M.; Unterbarnscheidt, T.; Herholt, A.; Wintgens, J. P.; Papiol, S.; Soto-Bernardini, M. C.; Kravchenko, M.; Zhang, M. et al.; Nave, K.-A.; Wichert, S. P.; Falkai, P.; Zhang, W.; Schwab, M. H.; Rossner, M. J.: Spironolactone is an antagonist of NRG1-ERBB4 signaling and schizophrenia-relevant endophenotypes in mice. Embo Molecular Medicine 9 (10), S. 1448 - 1462 (2017)

Goebbels, S.; Wieser, G. L.; Pieper, A.; Spitzer, S.; Weege, B.; Yan, K.; Edgar, J. M.; Yagensky, O.; Wichert, S. P.; Agarwal, A. et al.; Karram, K.; Renier, N.; Tessier-Lavigne, M.; Rossner, M. J.; Káradóttir, R. T.; Nave, K.-A.: A neuronal PI(3,4,5)P₃-dependent program of oligodendrocyte precursor recruitment and myelination. Nature Neuroscience 20 (1), S. 10 - 15 (2017)

Schmitt, A.; Martins-de-Souza, D.; Akbarian, S.; Cassoli, J. S.; Ehrenreich, H.; Fischer, A.; Fonteh, A.; Gattaz, W. F.; Gawlik, M.; Gerlach, M. et al.; Grünblatt, E.; Halene, T.; Hasan, A.; Hashimoto, K.; Kim, Y.-K.; Kirchner, S.-K.; Kornhuber, J.; Kraus, T. F. J.; Malchow, B.; Nascimento, J. M.; Rossner, M.; Schwarz, M.; Steiner, J.; Talib, L.; Thibaut, F.; Riederer, P.; Falkai, P.; WFSBP Task Force on Biological Markers: Consensus paper of the WFSBP task force on biological markers: Criteria for biomarkers and endophenotypes of schizophrenia Pt III: Molecular mechanisms. The World Journal of Biological Psychiatry 18 (5), S. 330 - 356 (2017)

Brzózka, M. M.; Rossner, M. J.; de Hoz, L.: Tcf4 transgenic female mice display delayed adaptation in an auditory latent inhibition paradigm. European Archives of Psychiatry and Clinical Neuroscience 266, S. 505 - 512 (2016)

Safaiyan, S.; Kannaiyan, N.; Snaidero, N.; Brioschi, S.; Biber, K.; Yona, S.; Edinger, A. L.; Jung, S.; Rossner, M. J.; Simons, M.: Age-related myelin degradation burdens the clearance function of microglia during aging. Nature Neuroscience 19, S. 995 - 998 (2016)

Brzózka, M. M.; Havemann-Reinecke, U.; Wichert, S. P.; Falkai, P.; Rossner, M. J.: Molecular signatures of psychosocial stress and cognition are modulated by chronic lithium treatment. Schizophrenia Bulletin 42 (Suppl. 1), S. S22 - S33 (2016)

Wehr, M. C.; Rossner, M. J.: Split protein biosensor assays in molecular pharmacological studies. Drug Discovery Today 21 (3), S. 415 - 429 (2016)

Brzózka, M. M.; Unterbarnscheidt, T.; Schwab, M. H.; Rossner, M. J.: OSO paradigm - a rapid behavioral screening method for acute psychosocial stress reactivity in mice. Neuroscience 314, S. 1 - 11 (2016)

Badowska, D.; Brzózka, M. M.; Chowdhury, A.; Malzahn, D.; Rossner, M. J.: Data calibration and reduction allows to visualize behavioural profiles of psychosocial influences in mice towards clinical domains. European Archives of Psychiatry and Clinical Neuroscience 265, S. 483 - 496 (2015)

Shahmoradi, A.; Radyushkin, K.; Rossner, M. J.: Enhanced memory consolidation in mice lacking the circadian modulators Sharp1 and -2 caused by elevated Igf2 signaling in the cortex. Proceedings of the National Academy of Sciences of the United States of America 112 (27), S. E3582 - E3589 (2015)

Falkai, P.; Rossner, M. J.; Schulze, T. G.; Hasan, A.; Brzózka, M. M.; Malchow, B.; Honer, W. G.; Schmitt, A.: Kraepelin revisited: schizophrenia from degeneration to failed regeneration. Molecular Psychiatry 20 (6), S. 671 - 676 (2015)

Schnell, C.; Shahmoradi, A.; Wichert, S. P.; Mayerl, S.; Hagos, Y.; Heuer, H.; Rossner, M. J.; Hülsmann, S.: The multispecific thyroid hormone transporter OATP1C1 mediates cell-specific sulforhodamine 101-labeling of hippocampal astrocytes. Brain Structure & Function 220 (1), S. 193 - 203 (2015)

Sharma, K.; Schmitt, S.; Bergner, C. G.; Tyanova, S.; Kannaiyan, N.; Manrique-Hoyos, N.; Kongi, K.; Cantuti, L.; Hanisch, U.-K.; Philips, M.-A. et al.; Rossner, M. J.; Mann, M.; Simons, M.: Cell type- and brain region-resolved mouse brain proteome. Nature Neuroscience 18 (12), S. 1819 - 1831 (2015)

Baier, P. C.; Brzózka, M.; Shahmoradi, A.; Reinecke, L.; Kroos, C.; Wichert, S. P.; Oster, H.; Wehr, M. C.; Taneja, R.; Hirrlinger, J. et al.; Rossner, M. J.: Mice lacking the circadian modulators SHARP1 and SHARP2 display altered sleep and mixed state endophenotypes of psychiatric disorders. PLoS One 9 (10), e110310 (2014)

Hsia, H.-E.; Kumar, R.; Luca, R.; Takeda, M.; Courchet, J.; Nakashima, J.; Wu, S.; Goebbels, S.; An, W.; Eickholt, B. J. et al.; Polleux, F.; Rotin, D.; Wu, H.; Rossner, M. J.; Bagni, C.; Rhee, J.-S.; Brose, N.; Kawabe, H.: Ubiquitin E3 ligase Nedd4-1 acts as a downstream target of PI3K/PTEN-mTORC1 signaling to promote neurite growth. Proceedings of the National Academy of Sciences of the United States of America 111 (36), S. 13205 - 13210 (2014)

Agarwal, A.; Zhang, M.; Trembak-Duff, I.; Unterbarnscheidt, T.; Radyushkin, K.; Dibaj, P.; Martins de Souza, D.; Boretius, S.; Brzózka, M. M.; Steffens, H. et al.; Berning, S.; Teng, Z.; Gummert, M. N.; Tantra, M.; Guest, P. C.; Willig, K. I.; Frahm, J.; Hell, S. W.; Bahn, S.; Rossner, M. J.; Nave, K.-A.; Ehrenreich, H.; Zhang, W.; Schwab, M. H.: Dysregulated expression of neuregulin-1 by cortical pyramidal neurons disrupts synaptic plasticity. Cell Reports 8 (4), S. 1130 - 1145 (2014)

Rossner, M. J.; Tirard, M.: Thy1.2 driven expression of transgenic His₆-SUMO2 in the brain of mice alters a restricted set of genes. Brain Research 1575, S. 1 - 11 (2014)

Quednow, B. B.; Brzózka, M. M.; Rossner, M. J.: Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective. Cellular and Molecular Life Sciences 71 (15), S. 2815 - 2835 (2014)

Prukop, T.; Epplen, D. B.; Nientiedt, T.; Wichert, S. P.; Fledrich, R.; Stassart, R. M.; Rossner, M. J.; Edgar, J. M.; Werner, H. B.; Nave, K.-A. et al.; Sereda, M. W.: Progesterone antagonist therapy in a Pelizaeus-Merzbacher mouse model. The American Journal of Human Genetics 94 (4), S. 533 - 546 (2014)

Steinberg, S.; de Jong, S.; Mattheisen, M.; Costas, J.; Demontis, D.; Jamain, S.; Pietiläinen, O. P. H.; Lin, K.; Papiol, S.; Huttenlocher, J. et al.; Sigurdsson, E.; Vassos, E.; Giegling, I.; Breuer, R.; Fraser, G.; Walker, N.; Melle, I.; Djurovic, S.; Agartz, I.; Tuulio-Henriksson, A.; Suvisaari, J.; Lönnqvist, J.; Paunio, T.; Olsen, L.; Hansen, T.; Ingason, A.; Pirinen, M.; Strengman, E.; Hougaard, D. M.; Ørntoft, T.; Didriksen, M.; Hollegaard, M. V.; Nordentoft, M.; Abramova, L.; Kaleda, V.; Arrojo, M.; Sanjuán, J.; Arango, C.; Etain, B.; Bellivier, F.; Méary, A.; Schürhoff, F.; Szoke, A.; Ribolsi, M.; Magni, V.; Siracusano, A.; Sperling, S.; Rossner, M.; Christiansen, C.; Kiemeney, L. A.; Franke, B.; van den Berg, L. H.; Veldink, J.; Curran, S.; Bolton, P.; Poot, M.; Staal, W.; Rehnstrom, K.; Kilpinen, H.; Freitag, C. M.; Magnusson, P.; Saemundsen, E.; Martsenkovsky, I.; Bikshaieva, I.; Martsenkovska, I.; Vashchenko, O.; Raleva, M.; Paketchieva, K.; Stefanovski, B.; Durmishi, N.; Pejovic Milevancevic, M.; Lecic Tosevski, D.; Silagadze, T.; Naneishvili, N.; Mikeladze, N.; Surguladze, S.; Vincent, J. B.; Farmer, A.; Mitchell, P. B.; Wright, A.; Schofield, P. R.; Fullerton, J. M.; Montgomery, G. W.; Martin, N. G.; Rubino, I. A.; van Winkel, R.; Kenis, G.; De Hert, M.; Réthelyi, J. M.; Bitter, I. I.; Terenius, L.; Jönsson, E. G.; Bakker, S.; van Os, J.; Jablensky, A.; Leboyer, M.; Bramon, E.; Powell, J.; Murray, R.; Corvin, A.; Gill, M.; Morris, D.; O'Neill, F. A.; Kendler, K.; Riley, B.; Wellcome Trust Case Control Consortium; Craddock, N.; Owen, M. J.; O'Donovan, M. C.; Thorsteinsdottir, U.; Kong, A.; Ehrenreich, H.; Carracedo, A.; Golimbet, V.; Andreassen, O. A.; Børglum, A. D.; Mors, O.; Mortensen, P. B.; Werge, T.; Ophoff, R. A.; Nöthen, M. M.; Rietschel, M.; Cichon, S.; Ruggeri, M.; Tosato, S.; Palotie, A.; St Clair, D.; Rujescu, D.; Collier, D. A.; Stefansson, H.; Stefansson, K.: Common variant at 16p11.2 conferring risk of psychosis. Molecular Psychiatry 19 (1), S. 108 - 114 (2014)